share_log

Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(11.0%),Tang Capital Management, LLC(11.0%), etc.

Aslan Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(11.0%),Tang Capital Management, LLC(11.0%)等

美股sec公告 ·  2023/07/13 16:57
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息